georgeob1 wrote:Perhaps so However in (say) Canada the care actually provided by the national health service is limited by the government's budget for it; the list of approved pharmaceuticals; the availability of specialists and the like. Demand is in the hands of individuals, but supply is determined by government - not private individuals and the market. I agree that in terms of available average public health data the system works well, however these differences make direct comparisons of cost highly suspect.
Why does it make the comparisons suspect? From a public policy viewpoint, what healthcare systems ultimately supply isn't products like pills and hospital beds; it isn't services like operations and CAT scans. It is, in a word, health: Infants delivered alive, diabetics controlling their blood sugar, epileptics free from seizures, cancer patients diagnosed and treated timely, people immune to infective diseases ....
The machineries providing these benefits differ from country to country. I agree
they are hard to compare. But their inputs and outputs are a different matter. They are transparent and readily comparable. I respectfully submit that you, George, just don't really
want them to be comparable, because the outcome of the comparison contradicts your deeply held views about economic policy.
georgeob1 wrote:To what extent do similar restrictions apply in Germany's insurance scheme?
In principle, these restrictions exist. In practice, they are almost never felt. I haven't yet researched the statistics, so I can only speak from personal experience. For whatever that's worth, I know quite a lot of people who needed expensive treatment, most of them because of old age, some of them because of chronic diseases, one of them because of a crippling accident. None of them was ever denied treatment, or even put on a waiting list.
georgeob1 wrote:Frankly taking your descriptions at face value, the systems in Germany and the US are similar indeed-- excepting only that ours is voluntary.
That's true in part, but only in part. From the patients' perspective, the systems are indeed quite similar. From the providers" perspective, though, they are quite different: The American system is voluntary on the provider's side, wheras the German system is not. This means German providers have to insure anyone who applies for a policy, and have to insure everyone for the same flat percentage of their gross income. (Insurers can set that percentage; it's one of the things they compete on.) These restrictions are enough to break the vicious cycle of adverse selection between patients and providers that prevents entirely free healthcare markets from performing efficiently.
All that said, I do think something like the German system would be a good compromise between "Medicare for all" and a purely free market. That's why I'm so pleased with the leading Democratic candidates, who seem to be shooting for just such a compromise.